betaxolol , a new beta-receptor blocking drug administered as a single dosage of 40 mg given orally , causes a maximal reduction of heart rate at rest of 30 % , during a submaximal exercise of 28 % and at rest after exercise of 33 % .
C0005320
betaxolol
C0428977
reduction